Literature DB >> 27544292

Left-Sided Surgical Ablation for Patients With Atrial Fibrillation Who Are Undergoing Concomitant Cardiac Surgical Procedures.

Niv Ad1, Sari D Holmes2, Deborah Lamont2, Deborah J Shuman2.   

Abstract

BACKGROUND: Growing evidence indicates the effectiveness of surgical ablation confined to the left atrium, especially with short duration of atrial fibrillation (AF) and smaller left atrial (LA) size. This study examined rhythm status and predictors of failure in this group of patients.
METHODS: Of 800 patients who underwent concomitant surgical ablation (2005 to 2015), 110 had LA-only ablation. Rhythm status was defined according to Heart Rhythm Society guidelines: sinus rhythm (SR) without class I/III antiarrhythmic drugs (AADs). Multivariate analyses examined predictors for SR without AADs. Predictors of failure were also stratified as age 75 years or older, LA size 5 cm or larger, AF duration 5 years or more, and nonparoxysmal AF type for secondary analyses.
RESULTS: Mean age was 70.7 ± 9.4 years, mean EuroSCORE II (European System for Cardiac Operative Risk Evaluation) was 4.7 ± 4.3%, mean LA size was 4.4 ± 0.8 cm, median (interquartile range) AF duration was 3.5 months (range, 0.4 to 21 months), 26% of patients were female, 59% had coronary artery bypass graft procedures, 36% had aortic valve procedures, and 25% had mitral valve procedures. SR without AADs at 6, 12, and 24 months was 82% (79 of 96), 87% (78 of 90), and 79% (61 of 77), respectively. The only independent predictor of SR without AADs at 6 months was smaller LA size (odds ratio, 0.35; p = 0.014). Return to SR without AADs at 6, 12, and 24 months was as follows: 92%, 93%, and 91%, respectively, for patients with no traditional predictors of failure (n = 32); 88%, 90%, and 77%, respectively, for one predictor (n = 47); and 66%, 76%, and 70% for two or more predictors (n = 31).
CONCLUSIONS: LA-only ablation yielded acceptable success rates, primarily in patients with shorter AF duration and smaller LA. However, success was reduced in patients with traditional predictors of failure. Well-designed studies with standardized lesion sets and ablation tools are required to determine whether full Cox maze yields better outcomes in patients with more advanced AF.
Copyright © 2017 The Society of Thoracic Surgeons. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2016        PMID: 27544292     DOI: 10.1016/j.athoracsur.2016.05.093

Source DB:  PubMed          Journal:  Ann Thorac Surg        ISSN: 0003-4975            Impact factor:   4.330


  6 in total

1.  Surgical management of atrial fibrillation at the time of septal myectomy.

Authors:  Eduard Quintana; James L Cox
Journal:  Ann Cardiothorac Surg       Date:  2017-07

2.  Early Stable Sinus Rhythm Associated With Greater Success 5 Years After Surgical Ablation.

Authors:  Niv Ad; Sari D Holmes
Journal:  Ann Thorac Surg       Date:  2018-01-08       Impact factor: 4.330

3.  Outcome of concomitant left atrial ablation during valvular heart surgery: an African perspective.

Authors:  Dambuza Nyamande; Risenga F Chauke; Siphosenkosi M Mazibuko; Shere P Ramoroko
Journal:  Cardiovasc J Afr       Date:  2021-09-13       Impact factor: 0.802

4.  Long-term outcome following concomitant mitral valve surgery and Cox maze procedure for atrial fibrillation.

Authors:  Niv Ad; Sari D Holmes; Paul S Massimiano; Anthony J Rongione; Lisa M Fornaresio
Journal:  J Thorac Cardiovasc Surg       Date:  2017-11-14       Impact factor: 5.209

5.  Five-year results of a modified left atrial maze IV procedure in the treatment of atrial fibrillation: a randomized study.

Authors:  Dengshen Zhang; Jun Shi; Huayan Quan; Lu Liu; Jian Zhang; Yingqiang Guo
Journal:  ANZ J Surg       Date:  2019-11-19       Impact factor: 1.872

6.  Left Atrial Function after Atrial Fibrillation Cryoablation Concomitant to Minimally Invasive Mitral Valve Repair: A Pilot Study on Long-Term Results and Clinical Implications.

Authors:  Matteo Anselmino; Chiara Rovera; Giovanni Marchetto; Davide Castagno; Mara Morello; Simone Frea; Fiorenzo Gaita; Mauro Rinaldi; Gaetano Maria De Ferrari
Journal:  Medicina (Kaunas)       Date:  2019-10-21       Impact factor: 2.430

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.